PRICE T ROWE ASSOCIATES INC /MD/
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 80255
BALTIMORE, MD
Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,907,188
+$893,758 QoQ
Shares Held
339,363
+20.4% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. FOLD ranks #119 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in FOLD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,907,188 | 339,363 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,013,430 | 281,842 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,320,184 | 1,055,861 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,994,811 | 1,046,215 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,469,817 | 1,283,066 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,892,597 | 1,368,641 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,331,716 | 1,341,921 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,789,266 | 1,390,047 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,366,672 | 1,389,361 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,544,709 | 1,377,358 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $16,988,674 | 1,397,095 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,491,230 | 1,392,614 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,291,231 | 1,469,002 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,195,280 | 1,490,195 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,229,036 | 1,458,720 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,744,786 | 1,465,995 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,836,910 | 1,461,131 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $23,852,390 | 2,065,142 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,522,718 | 2,777,248 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $24,752,396 | 2,567,676 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $20,606,439 | 2,085,672 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $47,319,768 | 2,049,362 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $16,821,678 | 1,191,337 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,908,495 | 1,121,253 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $8,776,567 | 949,845 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||